Kovid-19 continues to kill 1,000 Americans per day. But for those who develop dangerous cases of infection, advances in medical care and increased experience of doctors improve their chances of survival.
Since the first case in the US at the beginning of the year, medical professionals have stumbled into the dark for better understanding, working on drugs – such as steroids and blood thinners, and the antiviral drug Remedivir. The allocation of intensive care resources has improved. And doctors have learned to prohibit the use of ventilators for some patients, along with many other serious respiratory illnesses.
Doctors and experts say Andrew Badley, head of the Mayo Clinic’s Kovid Research Task Force, said improvements in medical strategy and earlier treatments are helping improve for very ill patients.
“Health care preparation today is so much better than in February and March,” Badley said in an interview. “We have better and more rapid access to diagnosis. We have more information about which drugs to use and which drugs not to use. We have more experimental treatments available. All of them Contributes to a possible improvement in mortality. “
One study adjusted the mortality rate of patients to be admitted to 4,689 Kovid-19 hospitalizations from March to June in New York, such as age, race, obesity, and any underlying diseases. In the first half of March, the mortality rate of hospitalized patients was 23%. By June, it had fallen to 8%. The research has not yet been peer-reviewed, a process through which other experts examine the work.
Despite the benefits, the US would soon pass 200,000 deaths, and each day thousands of Americans are confirmed to be infected. The number of people killed by the disease is still in large part, many of which have been previously infected – the more people get sick, the more people die. The Centers for Disease Control and Prevention has emphasized that for most people a mask is still the best available protection from the virus. And experts warn that the virus is still very dangerous and can even kill healthy individuals.
“Even with these improvements, it’s not a benign disease,” said Leora Horwitz, an associate professor of population health and medicine at New York University’s Grossman School of Medicine, who conducted a New York study of Kovid-19 hospitals. “This does not mean that coronavirus is now a dangerous disease. It is a very serious threat to public health.”
Public-health officials, epidemiologists, amateur observers and others have seen the epidemic unfold, looking for how to measure the death of the virus. Deaths as a percentage of overpopulation highlights the scope of the epidemic. The death rate is higher than what the death rate is expected to be. But neither method provides insight into whether the virus is becoming more or less fatal to a person with a severe case.
Experts said that even looking at the number of confirmed cases of death this could be misleading as the result is largely a function of testing. If many mild or asymptomatic cases are captured, the mortality rate will be reduced. In Europe, for example, there are real signs of a similar trend, although more cases can be found in younger, healthier people due to lower mortality. More infections among young people are also being found in America.
“You have to understand who you’re testing and then what the actual fatality rate is for that demographic,” said Aaron Glatt, head of infectious diseases at Mount Sinai South Nassau Hospital.
There is even a hypothesis that public health measures such as wearing and removing masks may help reduce the amount of people infected with the virus, which may lead to less severe cases because the body is at one time exposed to large amounts of the virus Do not get overwhelmed by the dose.
“Even though they are getting infected with the virus, they are probably falling short of a single dose of the virus and so they are getting sick less than it is right now,” Horwitz said.
In New York, the first major US city to be hit hard by the virus, knowledge among doctors was limited as cases were put into emergency rooms this spring. There have been more than 27,000 confirmed and potential Kovid-19 deaths in the city, most of them at the peak of the outbreak in March and April.
As its outbreak grew in other parts of the country, health caregivers in Texas had more time to work and learn.
“Before we started seeing a patient in Texas, we had a play book,” said Robert Hancock, president of the Texas College of Emergency Physician. “We understand things that work better with Kovid at this point.”
Since March, doctors have learned valuable lessons, not only on how to ensure hospitals do not run out of ICU beds and ventilators, but also to flip a patient on their abdomen, who is prone to prone conditions. Known as, may help. Giving steroids to patients frequently and treating them with blood thinners can also diagnose one’s disease.
“We now know that we may need these patients to start early on blood thinners and heparin, which is helping,” said Diana L. Fight, president of the Texas Medical Association. “Many of Kovid’s deaths are due to blood coagulation; blood clots ruin his organs.”
While there is still no cure for coronavirus, improvements in treatment and preventive measures all contribute to a better prognosis for patients combined, Fite said. According to the Texas State Department of Health Services, there have been at least 14,590 deaths from the virus in Texas.
“Even if these things don’t go well, they help improve a small percentage,” Fite said. “You add many of those things and you’ve got a better result overall.”
(Except for the headline, this story has not been edited by NDTV staff and published from a syndicated feed.)